Search research articles
Contact Us
Filters
Showing results (341-350 of 516) with videos related to
Page
of 52
Sort By:
Blood Advances
|
May 4, 2022
Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma
Ankit Kansagra, Angela Dispenzieri, Raphael Fraser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2019
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Sagar Lonial, Susanna Jacobus, Rafael Fonseca, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 18, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple Myeloma
Shaji Kumar, Betsy Knopf, Erik Asmus, et al.
British Journal of Haematology
|
May 10, 2017
Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma
Shaji Kumar, Philippe Moreau, Parameswaran Hari, et al.
Blood
|
January 12, 2012
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics
Shaji Kumar, Rafael Fonseca, Rhett P Ketterling, et al.
Blood Advances
|
December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Gareth P Gregory, Shaji Kumar, Ding Wang, et al.
American Journal of Hematology
|
January 3, 2022
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome
Marcella Kaddoura, Moritz Binder, David Dingli, et al.
American Journal of Hematology
|
July 18, 2018
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein
Marcella Tschautscher, Vincent Rajkumar, Angela Dispenzieri, et al.
Nature Communications
|
December 5, 2018
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression
Arianna Calcinotto, Arianna Brevi, Marta Chesi, et al.
American Journal of Hematology
|
February 19, 2019
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis
M Hasib Sidiqi, Surendra Dasari, Ellen D McPhail, et al.
Page
of 52
Search research articles
Search
Showing results (341-350 of 516) with videos related to
Sort By:
Page
of 52
Blood Advances
|
May 4, 2022
Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma
Ankit Kansagra, Angela Dispenzieri, Raphael Fraser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2019
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Sagar Lonial, Susanna Jacobus, Rafael Fonseca, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 18, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple Myeloma
Shaji Kumar, Betsy Knopf, Erik Asmus, et al.
British Journal of Haematology
|
May 10, 2017
Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma
Shaji Kumar, Philippe Moreau, Parameswaran Hari, et al.
Blood
|
January 12, 2012
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics
Shaji Kumar, Rafael Fonseca, Rhett P Ketterling, et al.
Blood Advances
|
December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Gareth P Gregory, Shaji Kumar, Ding Wang, et al.
American Journal of Hematology
|
January 3, 2022
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome
Marcella Kaddoura, Moritz Binder, David Dingli, et al.
American Journal of Hematology
|
July 18, 2018
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein
Marcella Tschautscher, Vincent Rajkumar, Angela Dispenzieri, et al.
Nature Communications
|
December 5, 2018
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression
Arianna Calcinotto, Arianna Brevi, Marta Chesi, et al.
American Journal of Hematology
|
February 19, 2019
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis
M Hasib Sidiqi, Surendra Dasari, Ellen D McPhail, et al.
Page
of 52